| 述评 |
|
|
|
|
| TcpC研究现状与展望 |
| 潘建平1，辛晓丽2 |
1.浙江大学城市学院医学院，浙江 杭州 310015； 2.浙江大学医学院基础医学系，浙江 杭州 310058; |
|
| Progress in TcpC research |
| PAN Jian-Ping1, XIN Xiao-Li2 |
| 1.Zhejiang University City College School of Medicine，Hangzhou 310015; 2.Department of Basic Medicine，Zhejiang University School of Medicine，Hangzhou 310058 |
| [1] |
MEDZHITOV R，JANEWAY C，Jr.Innate immune recognition: mechanisms and pathways [J].Immunol Rev，2000，173:89-97.
|
| [2] |
CIRL C，WIESER A，YADAV M，et al.Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins [J].Nat Med，2008，14 (4):399- 406.
|
| [3] |
SNYDER G A，CIRL C，JIANG J，et al.Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli [J].Proc Natl Acad Sci U S A，2013，110(17):6985-6990.
|
| [4] |
MAHJOUB-MESSAI F，BIDET P，CARO V，et al.Escherichia coli isolates causing bacteremia via gut translocation and urinary tract infection in young infants exhibit different virulence genotypes [J].J Infect Dis，2011，203(12):1844-1849.
|
| [5] |
STARCIC ERJAVEC M，JESENKO B，PETKOVSEK Z，et al.Prevalence and associations of tcpC，a gene encoding a Toll/interleukin-1 receptor domain-containing protein，among Escherichia coli urinary tract infection，skin and soft tissue infection，and commensal isolates [J].J Clin Microbiol，2010，48(3):966-968.
|
| [6] |
SCHUBERT S，NORENBERG D，CLERMONT O，et al.Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli [J].Int J Med Microbiol，2010，300(7):429- 434.
|
| [7] |
LI C，ZIENKIEWICZ J，HAWIGER J.Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway [J].J Biol Chem，2005，280(28):26152-26159.
|
| [8] |
AKIRA S，TAKEDA K.Toll-like receptor signalling [J].Nat Rev Immunol，2004，4(7):499-511.
|
| [9] |
IWASAKI A，MEDZHITOV R.Toll-like receptor control of the adaptive immune responses [J].Nat Immunol，2004，5(10):987-995.
|
| [10] |
KAWAI T，AKIRA S.TLR signaling [J].Cell Death Differ，2006，13(5):816-825.
|
| [11] |
MEDZHITOV R.Toll-like receptors and innate immunity [J].Nat Rev Immunol，2001，1(2):135-145.
|
| [12] |
AKIRA S，UEMATSU S，TAKEUCHI O.Pathogen recognition and innate immunity [J].Cell，2006，124 (4):783-801.
|
| [13] |
FEHLINGS M，DROBBE L，MOOS V，et al.Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells，macrophages，and monocytes [J].Infect Immun，2012，80(8):2724-2734.
|
| [14] |
YADAV M，ZHANG J，FISCHER H，et al.Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence [J].PLoS Pathog，2010，6(9):e1001120.
|
| [15] |
OSHIUMI H，MATSUMOTO M，FUNAMI K，et al.TICAM-1，an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction [J].Nat Immunol，2003，4(2):161-167.
|
| [16] |
AKIRA S.TLR signaling [J].Curr Top Microbiol Immunol，2006，311:1-16.
|
| [17] |
TANIGUCHI T，OGASAWARA K，TAKAOKA A，et al.IRF family of transcription factors as regulators of host defense [J].Annu Rev Immunol，2001，19:623-655.
|
| [18] |
HONDA K，TANIGUCHI T.IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors [J].Nat Rev Immunol，2006，6(9):644-658.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
